Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07688720 · ClinicalTrials.gov registry record · NA
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
A NA study, sponsored by Texas Christian University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07688720 is a NA study that is actively recruiting participants, run by Texas Christian University. The registered enrollment target is 20 participants.
The verdict
NCT07688720, a NA study, is actively recruiting participants, sponsored by Texas Christian University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Transcutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the intervention, during the intervention, and following the intervention.
Interventions
- DEVICE transcutaneous auricular neurostimulation (tAN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07688720
The ClinicalTrials.gov registry entry for NCT07688720 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Christian University, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transcutaneous auricular neurostimulation (tAN) is the first listed.
NCT07688720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07688720 about?
NCT07688720 is a clinical study titled "Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause". Transcutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the intervention, during t...
What is the current status of trial NCT07688720?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07688720?
The interventions under investigation include: transcutaneous auricular neurostimulation (tAN) (DEVICE).
Who is sponsoring clinical trial NCT07688720?
This trial is sponsored by Texas Christian University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.